Literature DB >> 15754090

Discrepancy between clinical and pathological diagnoses of CBD and PSP.

Toshiki Mizuno1, Kensuke Shiga, Yuriko Nakata, Junko Nagura, Taizen Nakase, Yoshihiro Ueda, Yoshiaki Takanashi, Kohji Urasaki, Yumiko Oyamada, Shinji Fushiki, Junji Nishikawa, Masahiro Yasuhara, Kenji Nakajima, Masanori Nakagawa.   

Abstract

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are often clinically confused with each other. Moreover, the discrepancy between clinical and pathological diagnoses of CBD and PSP are still controversial. We report here two atypical cases of PSP and CBD. A 73-year old woman was admitted with right hand rigidity, limb kinetic apraxia and cortical sensory loss. Brain atrophy, hypoperfusion and hypometabolism predominantly in the left frontoparietal lobes indicated CBD clinically. Pathological studies revealed neuronal loss and spongy change without ballooned neurons (BN) in the cerebral cortex. Modified Gallyas-Braak (G-B) staining revealed neurofibrillary tangles (NFTs) and tufted astrocytes, indicating pathological diagnosis of PSP. A 75-year-old man admitted with vertical gaze palsy, neck dystonia, parkinsonism and dementia. Atrophy of the frontal lobes and tegmentum of the midbrain and symmetrical frontal hypoperfusion in SPECT indicated PSP. However, neuronal loss and BN in the frontal lobes and clusters of astrocytic plaques indicated CBD pathologically. The G-B staining was useful for differentiating between CBD and PSP, but our atypical cases bring up a new issue about differential diagnosis of CBD and PSP.

Entities:  

Mesh:

Year:  2005        PMID: 15754090     DOI: 10.1007/s00415-005-0718-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

Review 2.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 3.  Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study.

Authors:  I Litvan; Y Agid; C Goetz; J Jankovic; G K Wenning; J P Brandel; E C Lai; M Verny; K Ray-Chaudhuri; A McKee; K Jellinger; R K Pearce; J J Bartko
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

4.  Unusual clinical presentations of cortical-basal ganglionic degeneration.

Authors:  C Bergeron; M S Pollanen; L Weyer; S E Black; A E Lang
Journal:  Ann Neurol       Date:  1996-12       Impact factor: 10.422

5.  [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy].

Authors:  M Hattori; M Yoshida; K Ojika; H Yuasa; S Mitake; Y Hashizume
Journal:  Rinsho Shinkeigaku       Date:  2000-04

6.  Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.

Authors:  T Komori; N Arai; M Oda; H Nakayama; H Mori; S Yagishita; T Takahashi; N Amano; S Murayama; S Murakami; N Shibata; M Kobayashi; S Sasaki; M Iwata
Journal:  Acta Neuropathol       Date:  1998-10       Impact factor: 17.088

7.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

8.  Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

Authors:  I Litvan; J J Hauw; J J Bartko; P L Lantos; S E Daniel; D S Horoupian; A McKee; D Dickson; C Bancher; M Tabaton; K Jellinger; D W Anderson
Journal:  J Neuropathol Exp Neurol       Date:  1996-01       Impact factor: 3.685

9.  Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy.

Authors:  H Mori; M Nishimura; Y Namba; M Oda
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.

Authors:  P R Hof; A Delacourte; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more
  2 in total

1.  Pathological laughter as onset symptom in atypical parkinsonisms.

Authors:  Anna De Rosa; Sabina Pappatà; Silvio Peluso; Francesco Saccà; Maria Lieto; Alessandro Filla; Giuseppe De Michele
Journal:  J Neurol       Date:  2016-11-24       Impact factor: 4.849

Review 2.  Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Authors:  Gesine Respondek; Carolin Kurz; Thomas Arzberger; Yaroslau Compta; Elisabet Englund; Leslie W Ferguson; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Christer Nilsson; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Jennifer L Whitwell; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Jean-Christophe Corvol; Carlo Colosimo; Richard Dodel; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw Morris; Peter Nestor; Wolfgang H Oertel; Gil D Rabinovici; James B Rowe; Thilo van Eimeren; Gregor K Wenning; Adam Boxer; Lawrence I Golbe; Irene Litvan; Maria Stamelou; Günter U Höglinger
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.